{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:49:23Z","timestamp":1786981763222,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05011-9","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T08:44:35Z","timestamp":1768121075000},"page":"2365-2389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiomics as a tool for predicting biochemical recurrence after total prostatectomy: a systematic review and meta\u2010analysis"],"prefix":"10.1007","volume":"58","author":[{"given":"Iman","family":"Kiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Toutounchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Broomand Lomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"issue":"2","key":"5011_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63","journal-title":"World J Oncol"},{"issue":"4","key":"5011_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G (2019) Current cancer epidemiology. J Epidemiol Glob Health 9(4):217\u2013222","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"5011_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5011_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","volume":"51","author":"MN Simmons","year":"2007","unstructured":"Simmons MN, Stephenson AJ, Klein EA (2007) Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 51(5):1175\u20131184","journal-title":"Eur Urol"},{"issue":"2","key":"5011_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41391-023-00711-0","volume":"27","author":"JW Moul","year":"2024","unstructured":"Moul JW et al (2024) Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis 27(2):202\u2013211","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5011_CR6","first-page":"1","volume":"42","author":"NI Simon","year":"2022","unstructured":"Simon NI et al (2022) Best Approaches and Updates for Prostate Cancer Biochemical Recurrence. Am Soc Clin Oncol Educ Book 42:1\u20138","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"5011_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-5347(05)64058-X","volume":"169","author":"GD Grossfeld","year":"2003","unstructured":"Grossfeld GD et al (2003) Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 169(1):157\u2013163","journal-title":"J Urol"},{"issue":"1","key":"5011_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12894-023-01350-2","volume":"23","author":"T Bejrananda","year":"2023","unstructured":"Bejrananda T, Pliensiri P (2023) Prediction of biochemical recurrence after laparoscopic radical prostatectomy. BMC Urol 23(1):183","journal-title":"BMC Urol"},{"issue":"1","key":"5011_CR9","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1038\/s41598-023-35821-1","volume":"13","author":"L Marin","year":"2023","unstructured":"Marin L, Casado F (2023) Prediction of prostate cancer biochemical recurrence by using discretization supports the critical contribution of the extra-cellular matrix genes. Sci Rep 13(1):10144","journal-title":"Sci Rep"},{"issue":"3","key":"5011_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3906\/sag-1303-128","volume":"44","author":"S \u00d6zkanli","year":"2014","unstructured":"\u00d6zkanli S et al (2014) Gleason score at the margin can predict biochemical recurrence after radical prostatectomy, in addition to preoperative PSA and surgical margin status. Turk J Med Sci 44(3):397\u2013403","journal-title":"Turk J Med Sci"},{"issue":"4","key":"5011_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441\u2013446","journal-title":"Eur J Cancer"},{"issue":"1","key":"5011_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01662-3","volume":"15","author":"G Yang","year":"2024","unstructured":"Yang G et al (2024) Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics. Insights Imaging 15(1):88","journal-title":"Insights Imaging"},{"issue":"6","key":"5011_CR13","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1016\/j.acra.2024.12.006","volume":"32","author":"NB Lomer","year":"2024","unstructured":"Lomer NB et al (2024) MRI-based radiomics for predicting prostate cancer grade groups: a systematic review and meta-analysis of diagnostic test accuracy studies. Acad Radiol. 32(6):3429\u20133452","journal-title":"Acad Radiol."},{"issue":"6","key":"5011_CR14","doi-asserted-by":"publisher","first-page":"065035","DOI":"10.1088\/2057-1976\/ad8201","volume":"10","author":"N Piran Nanekaran","year":"2024","unstructured":"Piran Nanekaran N et al (2024) Prediction of prostate cancer recurrence after radiotherapy using a fused machine learning approach: Utilizing radiomics from pretreatment T2W MRI images with clinical and pathological information. Biomed Phys Eng Exp 10(6):065035","journal-title":"Biomed Phys Eng Exp"},{"key":"5011_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.973285","volume":"12","author":"S Meng","year":"2022","unstructured":"Meng S et al (2022) Multiparametric MRI-based nomograms in predicting positive surgical margins of prostate cancer after laparoscopic radical prostatectomy. Front Oncol 12:973285","journal-title":"Front Oncol"},{"key":"5011_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04892-1","author":"M Salimi","year":"2025","unstructured":"Salimi M et al (2025) MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: a systematic review and meta-analysis. Abdom Radiol. https:\/\/doi.org\/10.1007\/s00261-025-04892-1","journal-title":"Abdom Radiol"},{"key":"5011_CR17","unstructured":"Page, M.J., et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj, 2021. 372."},{"issue":"1","key":"5011_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B et al (2024) METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging 15(1):8","journal-title":"Insights Imaging"},{"issue":"3","key":"5011_CR19","first-page":"40","volume":"7","author":"G Schwarzer","year":"2007","unstructured":"Schwarzer G (2007) Meta: an R package for meta-analysis. R News 7(3):40\u201345","journal-title":"R News"},{"issue":"3","key":"5011_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"key":"5011_CR21","unstructured":"Rohatgi, A., WebPlotDigitizer. Version 4.0. Austin, Texas, USA. 2017."},{"issue":"11","key":"5011_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta\u2010analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"1","key":"5011_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13207-4","volume":"24","author":"XH Wu","year":"2024","unstructured":"Wu XH et al (2024) Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy. BMC Cancer 24(1):1459","journal-title":"BMC Cancer"},{"issue":"3","key":"5011_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18383\/j.tom.2020.00029","volume":"6","author":"H Kang","year":"2020","unstructured":"Kang H et al (2020) Texture Analysis of F-18 Fluciclovine PET\/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results. Tomography 6(3):301\u2013307","journal-title":"Tomography"},{"issue":"3","key":"5011_CR25","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230143","volume":"6","author":"C Hu","year":"2024","unstructured":"Hu C et al (2024) Development and validation of a multimodality model based on whole-slide imaging and biparametric MRI for predicting postoperative biochemical recurrence in prostate cancer. Radiol Imaging Cancer 6(3):e230143","journal-title":"Radiol Imaging Cancer"},{"key":"5011_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103163","volume":"63","author":"L Li","year":"2021","unstructured":"Li L et al (2021) A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI. EBioMedicine 63:103163","journal-title":"EBioMedicine"},{"key":"5011_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040814","author":"V Bourbonne","year":"2020","unstructured":"Bourbonne V et al (2020) External validation of an MRI-derived radiomics model to predict biochemical recurrence after surgery for high-risk prostate cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040814","journal-title":"Cancers (Basel)"},{"issue":"10","key":"5011_CR28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41416-023-02441-5","volume":"129","author":"Y Hou","year":"2023","unstructured":"Hou Y et al (2023) Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence. Br J Cancer 129(10):1625\u20131633","journal-title":"Br J Cancer"},{"issue":"9","key":"5011_CR29","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1007\/s00259-024-06734-6","volume":"51","author":"T Li","year":"2024","unstructured":"Li T et al (2024) Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy. Eur J Nucl Med Mol Imaging 51(9):2806\u20132818","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5011_CR30","doi-asserted-by":"publisher","first-page":"153303382311667","DOI":"10.1177\/15330338231166766","volume":"22","author":"P An","year":"2023","unstructured":"An P et al (2023) Predicting Model of Biochemical Recurrence of Prostate Carcinoma (PCa-BCR) Using MR Perfusion-Weighted Imaging-Based Radiomics. Technol Cancer Res Treat 22:15330338231166766","journal-title":"Technol Cancer Res Treat"},{"key":"5011_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133416","author":"HW Lee","year":"2023","unstructured":"Lee HW et al (2023) Novel multiparametric magnetic resonance imaging-based deep learning and clinical parameter integration for the prediction of long-term biochemical recurrence-free survival in prostate cancer after radical prostatectomy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15133416","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5011_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00667-x","volume":"24","author":"C Hu","year":"2024","unstructured":"Hu C et al (2024) The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy. Cancer Imaging 24(1):23","journal-title":"Cancer Imaging"},{"key":"5011_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123098","author":"Y Yan","year":"2021","unstructured":"Yan Y et al (2021) Deep learning with quantitative features of magnetic resonance images to predict biochemical recurrence of radical prostatectomy: a multi-center study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13123098","journal-title":"Cancers (Basel)"},{"key":"5011_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841801","volume":"12","author":"R Shiradkar","year":"2022","unstructured":"Shiradkar R et al (2022) Prostate surface distension and tumor texture descriptors from pre-treatment MRI are associated with biochemical recurrence following radical prostatectomy: preliminary findings. Front Oncol 12:841801","journal-title":"Front Oncol"},{"key":"5011_CR35","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) Contrast-enhanced ultrasound-magnetic resonance imaging radiomics based model for predicting the biochemical recurrence of prostate cancer: a feasibility study. Comput Math Methods Med 2022:8090529","journal-title":"Comput Math Methods Med"},{"key":"5011_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184437","author":"SR Duenweg","year":"2023","unstructured":"Duenweg SR et al (2023) T2-weighted MRI radiomic features predict prostate cancer presence and eventual biochemical recurrence. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15184437","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5011_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00481-x","volume":"7","author":"WJ Gu","year":"2023","unstructured":"Gu WJ et al (2023) A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs. NPJ Precis Oncol 7(1):134","journal-title":"NPJ Precis Oncol"},{"key":"5011_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237322","author":"LM Huynh","year":"2023","unstructured":"Huynh LM et al (2023) Multi-institutional development and validation of a radiomic model to predict prostate cancer recurrence following radical prostatectomy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12237322","journal-title":"J Clin Med"},{"issue":"12","key":"5011_CR39","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3390\/cancers13123098","volume":"13","author":"Y Yan","year":"2021","unstructured":"Yan Y et al (2021) Deep learning with quantitative features of magnetic resonance images to predict biochemical recurrence of radical prostatectomy: a multi-center study. Cancers 13(12):3098","journal-title":"Cancers"},{"issue":"6","key":"5011_CR40","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","volume":"48","author":"L Papp","year":"2021","unstructured":"Papp L et al (2021) Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET\/MRI. Eur J Nucl Med Mol Imaging 48(6):1795\u20131805","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"22","key":"5011_CR41","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1002\/cncr.26169","volume":"117","author":"MR Cooperberg","year":"2011","unstructured":"Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117(22):5039\u20135046","journal-title":"Cancer"},{"issue":"2","key":"5011_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.eururo.2019.09.027","volume":"77","author":"R Zelic","year":"2020","unstructured":"Zelic R et al (2020) Predicting prostate cancer death with different pretreatment risk stratification tools: a head-to-head comparison in a nationwide cohort study. Eur Urol 77(2):180\u2013188","journal-title":"Eur Urol"},{"issue":"3","key":"5011_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10147-017-1236-5","volume":"23","author":"MB Hu","year":"2018","unstructured":"Hu MB et al (2018) Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus. Int J Clin Oncol 23(3):591\u2013598","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"5011_CR44","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.juro.2013.10.075","volume":"191","author":"DY Lichtensztajn","year":"2014","unstructured":"Lichtensztajn DY et al (2014) Prostate cancer risk profiles of Asian-American men: disentangling the effects of immigration status and race\/ethnicity. J Urol 191(4):952\u2013956","journal-title":"J Urol"},{"issue":"6","key":"5011_CR45","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/bju.14892","volume":"124","author":"Y Hou","year":"2019","unstructured":"Hou Y et al (2019) A machine learning-assisted decision-support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection. BJU Int 124(6):972\u2013983","journal-title":"BJU Int"},{"issue":"2","key":"5011_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jmri.25961","volume":"48","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Using support vector machine analysis to assess PartinMR: a new prediction model for organ-confined prostate cancer. J Magn Reson Imaging 48(2):499\u2013506","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"5011_CR47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.23736\/S0393-2249.19.03370-8","volume":"71","author":"A Martini","year":"2019","unstructured":"Martini A et al (2019) Clinical implications of prostatic capsular abutment or bulging on multiparametric magnetic resonance imaging. Minerva Urol Nefrol 71(5):502\u2013507","journal-title":"Minerva Urol Nefrol"},{"issue":"6","key":"5011_CR48","doi-asserted-by":"publisher","first-page":"293.e9","DOI":"10.1016\/j.urolonc.2023.03.011","volume":"41","author":"AB Galosi","year":"2023","unstructured":"Galosi AB et al (2023) The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy. Urol Oncol 41(6):293.e9-293.e14","journal-title":"Urol Oncol"},{"key":"5011_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110268","volume":"150","author":"L Yang","year":"2022","unstructured":"Yang L et al (2022) Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: a multiparametric MRI study according to PI-RADS version 2.1. Eur J Radiol 150:110268","journal-title":"Eur J Radiol"},{"issue":"5","key":"5011_CR50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/02841851251315717","volume":"66","author":"S Sirolu","year":"2025","unstructured":"Sirolu S et al (2025) Assessing the aggressiveness of prostate cancer using ADC and relaxation maps from synthetic MRI. Acta Radiol 66(5):536\u2013545","journal-title":"Acta Radiol"},{"issue":"40","key":"5011_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031076","volume":"101","author":"YH Chien","year":"2022","unstructured":"Chien YH et al (2022) Body composition and pelvic fat distribution are associated with prostate cancer aggressiveness and can predict biochemical recurrence. Medicine (Baltimore) 101(40):e31076","journal-title":"Medicine (Baltimore)"},{"key":"5011_CR52","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.2147\/CMAR.S250907","volume":"12","author":"JJ Mei","year":"2020","unstructured":"Mei JJ et al (2020) Association Between Contrast-Enhanced Ultrasound Indicators and Prostate Cancer Biochemical Recurrence After Treatment. Cancer Manag Res 12:4959\u20134968","journal-title":"Cancer Manag Res"},{"issue":"5","key":"5011_CR53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3348\/kjr.2018.0273","volume":"20","author":"I Joo","year":"2019","unstructured":"Joo I et al (2019) Dynamic contrast-enhanced ultrasound of gastric cancer: correlation with perfusion CT and histopathology. Korean J Radiol 20(5):781\u2013790","journal-title":"Korean J Radiol"},{"issue":"1110","key":"5011_CR54","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200035","volume":"93","author":"DM Emara","year":"2020","unstructured":"Emara DM et al (2020) Ultrasound elastography in characterization of prostatic lesions: correlation with histopathological findings. Br J Radiol 93(1110):20200035","journal-title":"Br J Radiol"},{"issue":"12","key":"5011_CR55","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.2967\/jnumed.122.263897","volume":"63","author":"F Moradi","year":"2022","unstructured":"Moradi F et al (2022) (68)Ga-PSMA-11 PET\/MRI in patients with newly diagnosed intermediate- or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment. J Nucl Med 63(12):1822\u20131828","journal-title":"J Nucl Med"},{"key":"5011_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745530","volume":"11","author":"X Qiu","year":"2021","unstructured":"Qiu X et al (2021) Prediction of biochemical recurrence after radical prostatectomy based on preoperative (68)Ga-PSMA-11 PET\/CT. Front Oncol 11:745530","journal-title":"Front Oncol"},{"issue":"9","key":"5011_CR57","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00259-022-05756-2","volume":"49","author":"MJ Roberts","year":"2022","unstructured":"Roberts MJ et al (2022) Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. Eur J Nucl Med Mol Imaging 49(9):3289\u20133294","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5011_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.898774","volume":"12","author":"SKB Spohn","year":"2022","unstructured":"Spohn SKB et al (2022) Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer. Front Oncol 12:898774","journal-title":"Front Oncol"},{"issue":"6","key":"5011_CR59","volume":"43","author":"S G\u00fclbahar Ate\u015f","year":"2024","unstructured":"G\u00fclbahar Ate\u015f S et al (2024) Primary tumor heterogeneity on pre-treatment [68Ga]Ga-PSMA PET\/CT for the prediction of biochemical recurrence in prostate cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 43(6):500032","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"issue":"2","key":"5011_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2):328\u2013338","journal-title":"Radiology"},{"issue":"6","key":"5011_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2967\/jnumed.118.219501","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope TA et al (2019) Metaanalysis of (68)Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology. J Nucl Med 60(6):786\u2013793","journal-title":"J Nucl Med"},{"key":"5011_CR62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","volume":"6","author":"RM Haralick","year":"1973","unstructured":"Haralick RM, Shanmugam K, Dinstein IH (1973) Textural features for image classification. IEEE Trans Syst Man Cybern 6:610\u2013621","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"5011_CR63","doi-asserted-by":"crossref","unstructured":"Laws, K.I., Textured image segmentation. 1981.","DOI":"10.21236\/ADA083283"},{"issue":"1","key":"5011_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jmri.25335","volume":"45","author":"K Gnep","year":"2017","unstructured":"Gnep K et al (2017) Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45(1):103\u2013117","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"5011_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200730","volume":"13","author":"G Penzias","year":"2018","unstructured":"Penzias G et al (2018) Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: preliminary findings. PLoS ONE 13(8):e0200730","journal-title":"PLoS ONE"},{"issue":"2s","key":"5011_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3545572","volume":"19","author":"S Jabeen","year":"2023","unstructured":"Jabeen S et al (2023) A review on methods and applications in multimodal deep learning. ACM Trans Multimed Comput Commun Appl 19(2s):1\u201341","journal-title":"ACM Trans Multimed Comput Commun Appl"},{"key":"5011_CR67","unstructured":"Salman, S. and X. Liu, Overfitting mechanism and avoidance in deep neural networks. arXiv preprint arXiv:1901.06566, 2019."},{"issue":"9","key":"5011_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3561048","volume":"55","author":"R Dwivedi","year":"2023","unstructured":"Dwivedi R et al (2023) Explainable AI (XAI): core ideas, techniques, and solutions. ACM Comput Surv 55(9):1\u201333","journal-title":"ACM Comput Surv"},{"issue":"2","key":"5011_CR69","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.euf.2024.10.005","volume":"11","author":"F Marino","year":"2024","unstructured":"Marino F et al (2024) Robot-assisted radical prostatectomy with the Hugo RAS and da Vinci surgical robotic systems: a systematic review and meta-analysis of comparative studies. European Urol Foc 11(2):312\u2013322","journal-title":"European Urol Foc"},{"issue":"9","key":"5011_CR70","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3390\/jcm13092551","volume":"13","author":"F Marino","year":"2024","unstructured":"Marino F et al (2024) Robot-assisted radical prostatectomy performed with the novel Hugo\u2122 RAS system: a systematic review and pooled analysis of surgical, oncological, and functional outcomes. J Clin Med 13(9):2551","journal-title":"J Clin Med"},{"key":"5011_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215927","volume":"550","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Prostate cancer treatment - China\u2019s perspective. Cancer Lett 550:215927","journal-title":"Cancer Lett"},{"issue":"9","key":"5011_CR72","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1007\/s13277-016-5116-9","volume":"37","author":"H Jiang","year":"2016","unstructured":"Jiang H et al (2016) Tmprss2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer. Tumour Biol 37(9):12397\u201312402","journal-title":"Tumour Biol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05011-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05011-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05011-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:04:52Z","timestamp":1782486292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05011-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":72,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5011"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05011-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}